| Id Number | 007954 |
| Date Posted | Aug 14, 2015 |
| Name | Jeramy |
| Gender | male |
| Age | 66 |
| Location | New York, NY, USA |
| I eat | 76%-95% Living/Raw Vegetarian Foods |
| Height | 5ft. 4in. |
| Weight | 56lbs. |
| Hair | zwORuvGN |
| Eyes | BZkDxNfGfpcNVrH |
| Occupation | pzygnFAqZwAihmpSIQ |
| Description | Three years revatio patient assistance "These data support our decision to submit a regulatory application for the vaccine candidate which, if successful, would bring us a step closer to having an additional tool to fight this deadly disease. We are grateful to the scientists across Africa and GSK and to our partners who have worked tirelessly for almost 30 years to bring us to this point." |
| Hobbies | Three years revatio patient assistance "These data support our decision to submit a regulatory application for the vaccine candidate which, if successful, would bring us a step closer to having an additional tool to fight this deadly disease. We are grateful to the scientists across Africa and GSK and to our partners who have worked tirelessly for almost 30 years to bring us to this point."
|
| Goals | Three years revatio patient assistance "These data support our decision to submit a regulatory application for the vaccine candidate which, if successful, would bring us a step closer to having an additional tool to fight this deadly disease. We are grateful to the scientists across Africa and GSK and to our partners who have worked tirelessly for almost 30 years to bring us to this point." |
| Quote | Three years revatio patient assistance "These data support our decision to submit a regulatory application for the vaccine candidate which, if successful, would bring us a step closer to having an additional tool to fight this deadly disease. We are grateful to the scientists across Africa and GSK and to our partners who have worked tirelessly for almost 30 years to bring us to this point." |
| Ideal Mate | Three years revatio patient assistance "These data support our decision to submit a regulatory application for the vaccine candidate which, if successful, would bring us a step closer to having an additional tool to fight this deadly disease. We are grateful to the scientists across Africa and GSK and to our partners who have worked tirelessly for almost 30 years to bring us to this point." |
| Contact | Click here to send an email to Jeramy |
